HK Stock MarketDetailed Quotes

MICROTECH MED-B (02235)

Watchlist

7.760
+0.010+0.13%

Not Open Jan 7 16:00 CST

3.24BMarket Cap-106.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MICROTECH MED-B (02235) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Turnover

63.07%245.93M

36.48%345.62M

36.10%150.82M

45.86%253.23M

54.29%110.81M

14.66%173.61M

--71.82M

101.13%151.4M

45.15%75.28M

--51.86M

Operating income

63.07%245.93M

36.48%345.62M

36.10%150.82M

45.86%253.23M

54.29%110.81M

14.66%173.61M

71.82M

101.13%151.4M

45.15%75.28M

51.86M

Cost of sales

----

-107.89%-80.52M

-39.43%-38.73M

---27.78M

Operating expenses

-69.24%-118.89M

-22.78%-162.77M

-32.05%-70.25M

-44.61%-132.56M

-32.83%-53.2M

-13.85%-91.67M

-40.05M

-107.89%-80.52M

-39.43%-38.73M

-27.78M

Gross profit

57.69%127.04M

51.53%182.85M

39.83%80.56M

47.27%120.67M

81.32%57.61M

15.59%81.94M

31.77M

93.97%70.88M

51.74%36.54M

24.08M

Selling expenses

7.45%-92.81M

-1.03%-207.14M

-45.51%-100.28M

-75.68%-205.02M

-76.72%-68.92M

-123.32%-116.7M

---39M

5.09%-52.26M

-103.90%-55.06M

---27M

Administrative expenses

7.62%-18.2M

7.57%-42.15M

12.68%-19.7M

-9.79%-45.6M

-57.54%-22.57M

-0.13%-41.53M

---14.32M

9.35%-41.48M

-36.12%-45.76M

---33.62M

Research and development expenses

5.74%-32.57M

-9.22%-76.56M

-7.91%-34.55M

-14.75%-70.1M

-30.23%-32.02M

-69.29%-61.09M

---24.59M

56.00%-36.08M

-63.82%-82.01M

---50.06M

Profit from asset sales

----

---8.31K

----

Revaluation surplus

-129.39%-41.27K

666.34%88.46K

--140.41K

---15.62K

----

-Changes in the fair value of other assets

-129.39%-41.27K

666.34%88.46K

--140.41K

---15.62K

----

Impairment and provision

-147.48%-9.97M

-15.42%-5.21M

-55.77%-4.03M

8.72%-4.51M

-388.64%-2.58M

-302.24%-4.94M

---529K

-553.72%-1.23M

55.56%-188K

---423K

-Other impairment is provision

-147.48%-9.97M

-15.42%-5.21M

-55.77%-4.03M

8.72%-4.51M

-388.64%-2.58M

-302.24%-4.94M

---529K

-553.72%-1.23M

55.56%-188K

---423K

Special items of operating profit

-50.37%3.35M

67.81%17.77M

595.41%6.76M

-53.19%10.59M

-34.77%971.96K

87.99%22.61M

--1.49M

-52.88%12.03M

192.92%25.53M

--8.72M

Operating profit

65.56%-25.08M

31.38%-134.02M

-6.80%-72.82M

-62.29%-195.31M

-49.23%-68.18M

-150.02%-120.35M

-45.69M

60.20%-48.14M

-54.45%-120.94M

-78.3M

Financing cost

-35.41%22.67M

-4.63%71.56M

-29.16%35.1M

-12.14%75.04M

31.06%49.55M

502,458.72%85.4M

--37.81M

94.48%-17K

0.96%-308K

---311K

Adjustment items of earning before tax

417.94%107.49K

84.93%-690.18K

-2.01%-33.81K

-4,796.74%-4.58M

47.39%-33.14K

---93.53K

---63K

----

Earning before tax

93.91%-2.3M

49.42%-63.15M

-102.27%-37.75M

-256.30%-124.85M

-134.97%-18.66M

27.23%-35.04M

-7.94M

60.29%-48.15M

-54.23%-121.25M

-78.61M

Tax

-61.29%4.54K

118.92%30.96K

--11.74K

-10,755.18%-163.62K

----

---1.51K

----

After-tax profit from continuing operations

93.92%-2.29M

49.51%-63.12M

-102.21%-37.74M

-256.75%-125.02M

-134.97%-18.66M

27.23%-35.04M

-7.94M

60.29%-48.15M

-54.23%-121.25M

-78.61M

Earning after tax

93.92%-2.29M

49.51%-63.12M

-102.21%-37.74M

-256.75%-125.02M

-134.97%-18.66M

27.23%-35.04M

-7.94M

60.29%-48.15M

-54.23%-121.25M

-78.61M

Minority profit

----

---241K

----

Profit attributable to shareholders

93.92%-2.29M

49.51%-63.12M

-102.21%-37.74M

-256.75%-125.02M

-134.97%-18.66M

27.23%-35.04M

-7.94M

60.21%-48.15M

-53.93%-121.01M

-78.61M

Basic earnings per share

94.44%-0.005

48.28%-0.15

-125.00%-0.09

-262.50%-0.29

-100.00%-0.04

38.46%-0.08

-0.02

66.67%-0.13

-39.29%-0.39

-0.28

Diluted earnings per share

94.44%-0.005

48.28%-0.15

-125.00%-0.09

-262.50%-0.29

-100.00%-0.04

38.46%-0.08

-0.02

66.67%-0.13

-39.29%-0.39

-0.28

Currency Unit

CNY

Accounting Standards

CAS (2007)

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

Ernst & Young

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Turnover	63.07%245.93M	36.48%345.62M	36.10%150.82M	45.86%253.23M	54.29%110.81M	14.66%173.61M	--71.82M	101.13%151.4M	45.15%75.28M	--51.86M
Operating income	63.07%245.93M	36.48%345.62M	36.10%150.82M	45.86%253.23M	54.29%110.81M	14.66%173.61M	71.82M	101.13%151.4M	45.15%75.28M	51.86M
Cost of sales	----	----	----	----	----	----	----	-107.89%-80.52M	-39.43%-38.73M	---27.78M
Operating expenses	-69.24%-118.89M	-22.78%-162.77M	-32.05%-70.25M	-44.61%-132.56M	-32.83%-53.2M	-13.85%-91.67M	-40.05M	-107.89%-80.52M	-39.43%-38.73M	-27.78M
Gross profit	57.69%127.04M	51.53%182.85M	39.83%80.56M	47.27%120.67M	81.32%57.61M	15.59%81.94M	31.77M	93.97%70.88M	51.74%36.54M	24.08M
Selling expenses	7.45%-92.81M	-1.03%-207.14M	-45.51%-100.28M	-75.68%-205.02M	-76.72%-68.92M	-123.32%-116.7M	---39M	5.09%-52.26M	-103.90%-55.06M	---27M
Administrative expenses	7.62%-18.2M	7.57%-42.15M	12.68%-19.7M	-9.79%-45.6M	-57.54%-22.57M	-0.13%-41.53M	---14.32M	9.35%-41.48M	-36.12%-45.76M	---33.62M
Research and development expenses	5.74%-32.57M	-9.22%-76.56M	-7.91%-34.55M	-14.75%-70.1M	-30.23%-32.02M	-69.29%-61.09M	---24.59M	56.00%-36.08M	-63.82%-82.01M	---50.06M
Profit from asset sales	----	----	----	----	----	---8.31K	----	----	----	----
Revaluation surplus	-129.39%-41.27K	666.34%88.46K	--140.41K	---15.62K	----	----	----	----	----	----
-Changes in the fair value of other assets	-129.39%-41.27K	666.34%88.46K	--140.41K	---15.62K	----	----	----	----	----	----
Impairment and provision	-147.48%-9.97M	-15.42%-5.21M	-55.77%-4.03M	8.72%-4.51M	-388.64%-2.58M	-302.24%-4.94M	---529K	-553.72%-1.23M	55.56%-188K	---423K
-Other impairment is provision	-147.48%-9.97M	-15.42%-5.21M	-55.77%-4.03M	8.72%-4.51M	-388.64%-2.58M	-302.24%-4.94M	---529K	-553.72%-1.23M	55.56%-188K	---423K
Special items of operating profit	-50.37%3.35M	67.81%17.77M	595.41%6.76M	-53.19%10.59M	-34.77%971.96K	87.99%22.61M	--1.49M	-52.88%12.03M	192.92%25.53M	--8.72M
Operating profit	65.56%-25.08M	31.38%-134.02M	-6.80%-72.82M	-62.29%-195.31M	-49.23%-68.18M	-150.02%-120.35M	-45.69M	60.20%-48.14M	-54.45%-120.94M	-78.3M
Financing cost	-35.41%22.67M	-4.63%71.56M	-29.16%35.1M	-12.14%75.04M	31.06%49.55M	502,458.72%85.4M	--37.81M	94.48%-17K	0.96%-308K	---311K
Adjustment items of earning before tax	417.94%107.49K	84.93%-690.18K	-2.01%-33.81K	-4,796.74%-4.58M	47.39%-33.14K	---93.53K	---63K	----	----	----
Earning before tax	93.91%-2.3M	49.42%-63.15M	-102.27%-37.75M	-256.30%-124.85M	-134.97%-18.66M	27.23%-35.04M	-7.94M	60.29%-48.15M	-54.23%-121.25M	-78.61M
Tax	-61.29%4.54K	118.92%30.96K	--11.74K	-10,755.18%-163.62K	----	---1.51K	----	----	----	----
After-tax profit from continuing operations	93.92%-2.29M	49.51%-63.12M	-102.21%-37.74M	-256.75%-125.02M	-134.97%-18.66M	27.23%-35.04M	-7.94M	60.29%-48.15M	-54.23%-121.25M	-78.61M
Earning after tax	93.92%-2.29M	49.51%-63.12M	-102.21%-37.74M	-256.75%-125.02M	-134.97%-18.66M	27.23%-35.04M	-7.94M	60.29%-48.15M	-54.23%-121.25M	-78.61M
Minority profit	----	----	----	----	----	----	----	----	---241K	----
Profit attributable to shareholders	93.92%-2.29M	49.51%-63.12M	-102.21%-37.74M	-256.75%-125.02M	-134.97%-18.66M	27.23%-35.04M	-7.94M	60.21%-48.15M	-53.93%-121.01M	-78.61M
Basic earnings per share	94.44%-0.005	48.28%-0.15	-125.00%-0.09	-262.50%-0.29	-100.00%-0.04	38.46%-0.08	-0.02	66.67%-0.13	-39.29%-0.39	-0.28
Diluted earnings per share	94.44%-0.005	48.28%-0.15	-125.00%-0.09	-262.50%-0.29	-100.00%-0.04	38.46%-0.08	-0.02	66.67%-0.13	-39.29%-0.39	-0.28
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion
Auditor	--	Tianjian Certified Public Accountants (Special General Partnership)	--	Tianjian Certified Public Accountants (Special General Partnership)	--	Ernst & Young	--	Ernst & Young	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?